🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Apotex Health Corp. (TSX:APTX)
Canada flag Canada · Delayed Price · Currency is CAD
41.70
+0.53 (1.29%)
Nov 19, 2026, 4:00 PM EST

Apotex Health Income Statement

Millions CAD. Fiscal year is Apr - Mar.
Fiscal Year
TTMFY 2026FY 2025FY 2024
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24
3,2063,4913,3502,940
Revenue Growth
-4.21%13.92%-
Cost of Revenue
1,5701,5481,5291,618
Gross Profit
1,6361,9431,8201,322
Selling, General & Admin
753.94635.01571.42502
Research & Development
168.16162.61216.04173.08
Other Operating Expenses
91.4475.1234.7918.57
Operating Expenses
1,014872.74822.25693.64
Operating Income
622.61,070997.98628.71
Interest Expense
-239.21-255.64-232.92-174.44
Interest & Investment Income
3.65.9913.6419.92
Currency Exchange Gain (Loss)
-20.95-5.8-25.037.65
Other Non Operating Income (Expenses)
-16.78-10.912.46-4.03
EBT Excluding Unusual Items
349.26803.62756.14477.82
Merger & Restructuring Charges
-90.74-110.32-79.74-437.98
Gain (Loss) on Sale of Assets
1.37-1.232.284.39
Asset Writedown
-81.65-72.28-8.02-
Legal Settlements
-64.52-69.88-154.1920.14
Other Unusual Items
-24.37-30.04-205.85-219.93
Pretax Income
89.35519.87310.63-155.56
Income Tax Expense
98.72146.09158.93-8.64
Net Income
-9.37373.78151.7-146.92
Net Income to Common
-9.37373.78151.7-146.92
Net Income Growth
-146.39%--
Shares Outstanding (Basic)
204193190179
Shares Outstanding (Diluted)
204193190179
Shares Change
-1.77%6.11%-
EPS (Basic)
-0.051.940.80-0.82
EPS (Diluted)
-0.071.910.80-0.82
EPS Growth
-139.14%--

Additional Metrics

Fiscal Year
TTMFY 2026FY 2025FY 2024
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24
Free Cash Flow
202.42519.9460.84487.65
Free Cash Flow Per Share
0.992.692.432.73
Dividend Per Share
0.060-6.4795.059
Dividend Growth
--28.05%-
Gross Margin
51.03%55.65%54.34%44.97%
Operating Margin
19.42%30.65%29.79%21.38%
Profit Margin
-0.29%10.71%4.53%-5.00%
Free Cash Flow Margin
6.31%14.89%13.76%16.58%
EBITDA
767.341,1891,104748.62
EBITDA Margin
23.94%34.06%32.95%25.46%
D&A For EBITDA
144.74119.04105.9119.91
EBIT
622.61,070997.98628.71
EBIT Margin
19.42%30.65%29.79%21.38%
Effective Tax Rate
110.48%28.10%51.16%-